Arkolith/Insider Trading/BMEA/Form 4

A2A Pharmaceuticals, Inc.

10% OwnerBiomea Fusion, Inc. (BMEA) · full profile →Form 4 · filed Jun 2, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.3M
Net Open-Market Flow
-$4.3M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2023Sell(S)50K$34.56$1.7M3.5M
May 31, 2023Sell(S)75K$33.81$2.5M3.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001859061-23-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML